Abstract
Adenosquamous carcinoma (ASC) is characterized by the presence of adenocarcinoma and squamous cell carcinoma components in one tumor. Primary appendiceal ASC is extremely rare, and only 7 cases have been reported in the medical literature. We present a case of primary appendiceal ASC, where both tumor components were subjected to next-generation sequencing. Both components shared the same BRAF, TP53, PLCG2 , and RUNX1 variants, but only the adenocarcinoma component demonstrated a mutation in the SMAD4 gene. This suggests appendiceal ASC components may diverge from a shared evolutionary clone. We then discuss the therapeutic implications of our findings. To our knowledge, this is the first next-generation sequencing analysis performed on appendiceal ASC.
| Original language | English (US) |
|---|---|
| Article number | 300816 |
| Journal | Human Pathology Reports |
| Volume | 43 |
| DOIs | |
| State | Published - Mar 2026 |
Bibliographical note
Publisher Copyright:© 2026 The Authors.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenocarcinoma
- Adenosquamous carcinoma
- Appendix
- Next-generation sequencing
- Squamous cell carcinoma
Fingerprint
Dive into the research topics of 'Primary adenosquamous carcinoma of the appendix with genomic profiling of the adenocarcinoma and squamous cell carcinoma components using next-generation sequencing'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS